The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...

To accomplish this, a retrospective case series study was conducted involving 76 patients previously diagnosed with dry eye and exhibiting unsatisfactory responses to various prior clinical treatments ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

Ocugen ( NASDAQ: OCGN) disclosed on Tuesday that its gene therapy candidate, OCU410ST, has been granted rare pediatric ...